 Inhibitory effects procainamide sympathetic nerve activity humans experimental animals procainamide hypotension reductions efferent vasoconstrictor sympathetic ganglionic blockade central nervous system sympathetic inhibition hypothesis sympathetic nerve activity SNA humans postganglionic SNA normal subjects baseline state infusions procainamide HCl mg/min mg/min maintenance end loading infusion mean arterial pressure MAP mean SEM mm Hg central venous pressure mm Hg forearm vascular resistance FVR resistance units SNA units/min changes maintenance infusion levels SNA FVR MAP cold pressor test intravenous procainamide subjects intravenous procainamide HCl mg/kg mg/min dose-dependent inhibition SNA blood concentrations drug washout procainamide causes direct vasodilation subjects infusions brachial artery doses systemic effect Ipsilateral FVR local intra-arterial infusion procainamide data intravenous procainamide hypotension vasodilation sympathetic withdrawal Vasodilation direct vasorelaxant effect drug